August 2013
In This Issue
Stay Connected

Like us on FacebookFollow us on TwitterView our profile on LinkedIn
A Note from Jennifer
Dear WIPO Re:Search Members and Friends, 


I am pleased to confirm the 2013 WIPO Re:Search Annual Meeting will be held in conjunction with the European & Developing Countries Clinical Trials Partnership (EDCTP) Seventh Forum on October 21st in Dakar, Senegal. WIPO evaluated options and obtained feedback from Members before confirming date and location of the meeting.  We expect to have strong representation from Members at the annual meeting, which will focus on research organizations from African countries.  As more details become available, WIPO and BVGH will share them with you.

Last month, I had the pleasure of moderating a panel session titled "1+1=3: The Power of Partnerships" at the Washington Biotechnology & Biomedical Association's 2013 Life Sciences Innovation Northwest conference in Seattle.  WIPO Re:Search Members Michael Strange from GlaxoSmithKline and Anurag Mairal from PATH represented WIPO Re:Search on the panel.  Read more about the conference and activities in this month's Snapshot.


Please forward this Snapshot to your colleagues and reach out to us with any partnering requests or ideas.


 Jennifer Dent

President, BVGH 


Jennifer Dent moderated a panel and was interviewed by Jack Farris, Past President and CEO, WBBA, at the Washington Biotechnology WBBA logo & Biomedical Association's 2013 Life Science Innovation Northwest conference in Seattle last month. You can view exclusive interviews of Jennifer discussing Biotechnology and Global Health and BVGH board member, Steven Burrill, CEO, Burrill & Company, presenting a view on Growth in Biotechnology. The panel session, "1+1 = 3: The Power of Partnerships," moderated by Jennifer, included panelists Natalie Dakers, CEO, The Center for Drug Research and Development, Wenyong Wang, Managing Director, Burrill & Company, Ling Wong, Program Officer and Program Investment Officer, the Bill & Melinda Gates Foundation, Anurag Mairal, Global Program Leader, Technology Solutions Global Program, PATH, and Michael Strange, Head of Operations, Tres Cantos Medicines Development Campus, GlaxoSmithKline. While at the event, Jennifer had the opportunity to speak with numerous individuals from local, national, and international biotechnology organizations. Videos of Jennifer's and Steven's interviews can be found online. Recaps of the plenary and sessions can be found on the WBBA's website.
Jennifer speaks during the panel session while Anurag Mairal (PATH) (right) listens in.
Jennifer and Katy Graef attended an Open House event at Seattle BioMed. During the event, which included a poster session and tours of Seattle BioMed's insectarium, Alan Aderem, President and Full Professor, Seattle BioMed, gave a brief outline of the institution's current research and its most recent successes. The event presented an opportunity to connect with several Seattle BioMed researchers including Kevin Urdahl, Assistant Professor, who studies the role of regulatory T cells (T regs) during tuberculosis infection, and Joe Smith, Associate Professor, whose laboratory focuses on cytoadherence of Plasmodium falciparum-infected erythrocytes.
TTS Ltd. Logo Roopa Ramamoorthi attended the Tech Transfer Summit North America 2013 conference, organized by TTS Ltd. at the UCSF Mission Bay campus in San Francisco. During the event, she met with several directors from WIPO Re:Search Founding Pharmaceutical Members to discuss WIPO Re:Search collaboration opportunities including Roxanne Duan, Director, Academic Partnering, MedImmune, AstraZeneca, Alex Szidon, Director, Operational Alliances, Novartis, and Sylvaine Cases, Director, External Innovation, Science Policy and External Innovation, Sanofi R&D Strategy, Sanofi. Roopa also met with and described WIPO Re:Search to potential new Members. 
PHCPartnership Hub Central


Founding member, AstraZeneca, and scientists at the Anti-Wolbachia Consortium (A-WOL) at the Liverpool School of Tropical Medicine (LSTM) in Liverpool, UK, finalized an agreement that will enable LSTM scientists to utilize AstraZeneca's new High-Throughput Screen Center. The Center, which 
AZ Logo small
has over 1.8 million compounds, will host LSTM scientistsLiverpool STM LOGO
while they screen compounds against Wolbachia, an essential bacterium for the nematodes that cause onchocerciasis and lymphatic filariasis.  More information regarding this new collaboration can be obtained at AstraZeneca's Lab Talk blog. See this month's highlighted contributions for more information about this high-throughput screen opportunity.
HCHighlighted Contribution 


Featured this month is AstraZeneca's new High-Throughput Screen Center and their commitment to allow its use, byAZ Logo small WIPO Re:Search members, for three screens each year. AstraZeneca will enable members to screen their full collection or large libraries to identify and determine potency of small molecule hits against novel targets for NTDs. 


For more information or to discuss potential collaborations regarding this technology, please contact Roopa Ramamoorthi.  

WIPOWIPO Re:Search Member in the News

The Massachusetts Institute of Technology (MIT) News published an article describing a novel method for growing liver tissue that supports infection with liver-stage malaria parasites developed by Sangeeta Bhatia, John J. and Dorothy Wilson Professor of Health Sciences and Technology & Electrical Engineering and Computer Science. This article follows the recent publication of Sangeeta's research in the July 17th issue of Cell Host & Microbe
EventsTableUpcoming Global Health Events

Event Title
Web Link
Sept. 8-12
Molecular Parasitology Meeting
Woods Hole, MA, USA
Sept. 16-19
International Leprosy Congress
Brussels, Belgium

Are you attending a global health event?
Do you have a Research Request to highlight in the Snapshot?

We want to hear from you! Please send feedback and suggestions via email.

WIPO Re:Search Founding Supporters
Founding Sponsor Logos

Copyright © 2012. All Rights Reserved.